Vardhan launches India's first indigenously developed pneumococcal vaccine 'Pneumosil'
During clinical trials, Pneumosil was found to be safe and effective in the prevention of pneumonia and based on which Pneumosil has been licensed by the Drugs Controller General of India in July 2020 after approval from subject expert committee (SEC), he said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 28, 2020 Category: Pharmaceuticals Source Type: news

Serum Institute develops first indigenous vaccine against pneumonia; to be launched next week
India's drug regulator in July had granted market approval for the Pneumococcal Polysaccharide Conjugate vaccine, after reviewing the phase 1, 2 and 3 clinical trial data submitted by the Pune-based firm. (Source: The Economic Times)
Source: The Economic Times - December 24, 2020 Category: Consumer Health News Source Type: news

Intellectual Property Monopolies Block Vaccine Access
By Anis Chowdhury and Jomo Kwame SundaramSYDNEY and KUALA LUMPUR, Dec 15 2020 (IPS) Just before the World Health Assembly (WHA), an 18 May open letter by world leaders and experts urged governments to ensure that all COVID-19 vaccines, treatments and tests are patent-free, fairly distributed and available to all, free of charge. Pious promises Leaders of Italy, France, Germany, Norway and the European Commission called for the vaccine to be “produced by the world, for the whole world” as a “global public good of the 21st century”, while China’s President Xi promised a vaccine developed by Chi...
Source: IPS Inter Press Service - Health - December 15, 2020 Category: International Medicine & Public Health Authors: Anis Chowdhury and Jomo Kwame Sundaram Tags: Civil Society Development & Aid Economy & Trade Featured Global Headlines Health Human Rights Humanitarian Emergencies Poverty & SDGs TerraViva United Nations Jomo Kwame Sundaram & Anis Chowdhury Source Type: news

Cells to Society: Year of the Nurse / Global Impact
This article provides a theoretical clarification of the concept "social cohesion" as it relates to health behaviors and outcomes, uncovering the critical attributes, antecedents, and consequences of social cohesion and reflecting on its future in health literature.     Read more   View More Research ...
Source: Johns Hopkins University and Health Systems Archive - December 11, 2020 Category: Nursing Source Type: news

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Background A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of four tr ials. Methods This analysis includes data from four ongoing blinded, randomised, controlled trials done across the UK, Brazil, and South Africa. Participants aged 18 years and older were randomly assigned (1:1) to ChAdOx1 nCoV-19 vaccine or control (meningococcal group A, C, W, and Y conjugate vac cine or saline). ...
Source: Current Awareness Service for Health (CASH) - December 9, 2020 Category: Consumer Health News Source Type: news

Meningococcus B vaccine prevents disease with 79 per cent effectiveness in under 18s
Meningococcus group B, the most prevalent strain of meningococcal infection, is prevented with 79 per cent effectiveness in children and young adults inoculated with the 4CMenB vaccine, also known as Bexsero, according to a new collaborative study from researchers in Portugal and the UK and led by the University of Bristol which evaluated the vaccine ’ s performance in a real-world setting. The findings are published today [1 December] in the Journal of the American Medical Association (JAMA). (Source: University of Bristol news)
Source: University of Bristol news - December 1, 2020 Category: Universities & Medical Training Tags: Health, International, Research; Faculty of Health Sciences, Faculty of Health Sciences, Population Health Sciences, Faculty of Life Sciences, Faculty of Life Sciences, School of Cellular and Molecular Medicine; Press Release Source Type: news

Meningococcus B vaccine prevents disease with 79 per cent effectiveness in under-18s
(University of Bristol) Meningococcus group B, the most prevalent strain of meningococcal infection, is prevented with 79 per cent effectiveness in children and young adults inoculated with the 4CMenB vaccine, also known as Bexsero, according to a new collaborative study from researchers in Portugal and the UK and led by the University of Bristol which evaluated the vaccine's performance in a real-world setting. The findings are published today [1 December] in the Journal of the American Medical Association (JAMA). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 1, 2020 Category: International Medicine & Public Health Source Type: news

An AstraZeneca Manufacturing Error Is Clouding Vaccine Study Results
LONDON — AstraZeneca and Oxford University on Wednesday acknowledged a manufacturing error that is raising questions about preliminary results of their experimental COVID-19 vaccine. A statement describing the error came days after the company and the university described the shots as “highly effective” and made no mention of why some study participants didn’t receive as much vaccine in the first of two shots as expected. In a surprise, the group of volunteers that got a lower dose seemed to be much better protected than the volunteers who got two full doses. In the low-dose group, AstraZeneca said,...
Source: TIME: Health - November 26, 2020 Category: Consumer Health News Authors: DANICA KIRKA / AP Tags: Uncategorized COVID-19 overnight wire Source Type: news

Directed enhanced service specification for flu updated
An updated directed enhanced service specification (DES) for the seasonal flu and pneumococcal vaccination programme 2020/21 has been published. (Source: NHS Networks)
Source: NHS Networks - November 9, 2020 Category: UK Health Source Type: news

Two Thirds of US Teens Fail to Get Needed Vaccines Two Thirds of US Teens Fail to Get Needed Vaccines
Completion rates vary from 11.3% in Idaho to 56.4% in Rhode Island. Provider visits at age 16 or 17 and mandates for meningococcal ACWY are keys to uptake, researcher says.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - October 23, 2020 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

Vaccination Coverage Among U.S. Adolescents Aged 13-17 Vaccination Coverage Among U.S. Adolescents Aged 13-17
Data in this report indicates that adolescent vaccination coverage in the United States continues to improve for HPV and for meningococcal vaccines, but disparities remain.Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 21, 2020 Category: Consumer Health News Tags: Public Health & Prevention Journal Article Source Type: news

A single-center prospective cohort study on postsplenectomy sepsis and its prevention
This study evaluated the impact of a dedicated outpatient service on vaccination uptake after splenectomy and on the incidence of postsplenectomy sepsis. Methods. From 2009 to 2016 at the University Hospital Freiburg (Germany), asplenic patients were referred to a dedicated outpatient service, provided with comprehensive preventive care including vaccinations, and enrolled in a prospective cohort study. The impact of the service on vaccination uptake and the occurrence of severe sepsis/septic shock was compared between patients who had splenectomy (or were asplenic) within 3 months of study entry ( " early study entry...
Source: Current Awareness Service for Health (CASH) - October 9, 2020 Category: Consumer Health News Source Type: news

South Africa: How Changing Vaccine Schedules Can Save Costs and Lives
[The Conversation Africa] In 2005, before most low- and middle-income countries started vaccinating children routinely for pneumococcal disease, it caused approximately 1.5 million deaths worldwide annually. About 700,000 to 1 million of these deaths were in children under five years. Pneumococcal disease occurs when Streptococcus pneumoniae invades a normally sterile area of the body, causing meningitis, pneumonia, septicaemia or other disease syndromes. Case fatality rates are very high for septicaemia (>20%) and meningitis (& (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 29, 2020 Category: African Health Source Type: news

ACIP Provides Recommendations on Meningococcal Vaccination
FRIDAY, Sept. 25, 2020 -- Routine vaccination with a quadrivalent meningococcal conjugate vaccine (MenACWY) is recommended for adolescents aged 11 to 12 years with a booster at age 16 years, according to a report published in the Sept. 24 issue of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 25, 2020 Category: Pharmaceuticals Source Type: news

Massachusetts Has Highest Vaccination Rate In America, Report Says
cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p1").init({"mcp":"cbs","width":"100%","height":"100%","video":"4698051","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p1","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - September 15, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated CBSN Boston Syndicated Local Vaccines Source Type: news

The COVID-19 Pandemic Has Erased Decades of Progress on Childhood Vaccination
While the world waits for a COVID-19 vaccine, children across the globe are going without shots already known to be life-saving. With the world in disarray due to the COVID-19 pandemic, the number of children vaccinated this year against infections like diphtheria, tetanus, pertussis, measles and pneumococcal disease has fallen to levels not seen since the 1990s, according to a new report from the Bill and Melinda Gates Foundation. “In other words,” the report reads, “we’ve been set back about 25 years in about 25 weeks.” That stark figure comes from the Gates Foundation’s annual Goalkee...
Source: TIME: Health - September 15, 2020 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 Source Type: news

Vaccine proves effective against the most severe type of pneumonia
(Murdoch Childrens Research Institute) A pneumococcal vaccine was effective at protecting children in Laos against the most severe type of pneumonia, a new study has found. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 10, 2020 Category: International Medicine & Public Health Source Type: news

Directed Enhanced Service Specification Seasonal influenza and pneumococcal polysaccharide vaccination programme 2020/21
All GP practices are expected to provide essential and those additional services they are contracted to provide to all their patients. This enhanced service specification outlines more specialised services to be provided. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 8, 2020 Category: Consumer Health News Source Type: news

Seasonal influenza DES specification – updated
The Influenza and Pneumococcal Immunisation Directed Enhanced Service specification has been amended and republished to provide for additional new cohorts of patients to be vaccinated in general practice. (Source: NHS Networks)
Source: NHS Networks - September 6, 2020 Category: UK Health Source Type: news

Updated flu DES offers little detail as GPs face 'one year at a time' updates on expanded campaign
GP practices will receive the same £10.06 fee per vaccination as last year under the 2020/21 flu and pneumococcal DES, as the government insisted plans for the 'biggest flu campaign ever' would go ahead despite a lack of detail in the updated specification. (Source: GP Online News)
Source: GP Online News - September 4, 2020 Category: Primary Care Tags: Contracts & funding Source Type: news

In-Hospital Heart Failure Deaths Down With Routine Vaccinations
TUESDAY, Sept. 1, 2020 -- For patients with heart failure, influenza and pneumococcal vaccinations are associated with lower in-hospital mortality, according to a study presented at the European Society of Cardiology Congress 2020: The Digital... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 1, 2020 Category: Pharmaceuticals Source Type: news

Vaccine narrows racial disparities in pneumococcal disease
(Vanderbilt University Medical Center) In a major public health success, the introduction of pneumococcal conjugate vaccine PCV13, or Prevnar 13, in 2010 in the United States is associated with reduction in socioeconomic disparities and the near elimination of Black-white-based racial disparities for invasive pneumococcal disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 31, 2020 Category: International Medicine & Public Health Source Type: news

Flu, Pneumonia Vaccination Tied to Lower Dementia Risk Flu, Pneumonia Vaccination Tied to Lower Dementia Risk
Influenza and pneumococcal vaccination may lower risk for the development of Alzheimer's disease in older adults, two large observational studies suggest.Medscape Medical News (Source: Medscape Med Students Headlines)
Source: Medscape Med Students Headlines - July 28, 2020 Category: Universities & Medical Training Tags: Psychiatry News Source Type: news

Morocco: Hospitals to Be Supplied With Influenza and Pneumococcal Vaccines This Autumn (Minister)
[MAP] Rabat -- Moroccan hospitals will be supplied with influenza and pneumococcal vaccines during the coming autumn, Health minister Khalid Ait Taleb announced on Saturday. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 26, 2020 Category: African Health Source Type: news

Oxford ’s COVID-19 Vaccine Candidate Takes a Big Leap Forward, Showing Success in Early Trials
The foot race to develop the first effective vaccine against COVID-19 involves an awfully crowded field, with 137 candidate vaccines in pre-clinical study worldwide and another 23 actually in development. But a leader seemed to emerge today with research published in the Lancet reporting promising results in a robust study by investigators at Oxford University in England. The study began in April, with a sample group of 1,077 adults aged 18 to 55—an age group young enough to tolerate exposure to SARS-CoV2, the virus that causes COVID-19, with less risk of adverse effects than would be seen in older, more vulnerable a...
Source: TIME: Health - July 20, 2020 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized COVID-19 Source Type: news

COVID-19 vaccine AZD1222 showed robust immune responses in all participants in Phase I/II trial
Interim results from the ongoing Phase I/II COV001 trial, led by Oxford University, showed AZD1222 was tolerated and generated robust immune responses against the SARS-CoV-2 virus in all evaluated participants. COV001 is a blinded, multi-centre, randomised controlled Phase I/II trial with 1,077 healthy adult participants, aged 18-55 years. It assessed a single dose of AZD1222 against a comparator meningococcal conjugate vaccine, MenACWY. (Source: World Pharma News)
Source: World Pharma News - July 20, 2020 Category: Pharmaceuticals Tags: Featured AstraZeneca Business and Industry Source Type: news

Coronavirus Remains Front and Center at June ACIP Meeting
The CDC's Advisory Committee on Immunization Practices met virtually June 24 to discuss topics related to the COVID-19 pandemic and issues pertaining to vaccines for influenza and meningococcal disease. (Source: AAFP News)
Source: AAFP News - July 1, 2020 Category: Primary Care Source Type: news

Clinical guidance for healthcare professionals on maintaining immunisation programmes during COVID-19, NHS England (updated 29th June 2020)
The national immunisation programme is highly successful in reducing the incidence of serious and sometimes life-threatening diseases such as pneumococcal and meningococcal infections, whooping cough, diphtheria and measles. It remains important to maintain the best possible vaccine uptake to prevent a resurgence of these infections. This will also prevent increasing further the numbers of patients requiring health services, as well as outbreaks of vaccine-preventable diseases, and allow us to provide important protection to children and other vulnerable groups. Where possible, the routine immunisation programmes should be...
Source: Current Awareness Service for Health (CASH) - June 29, 2020 Category: Consumer Health News Source Type: news

Flu Vaccine Only 39% Effective This Past Season, CDC Panel Says Flu Vaccine Only 39% Effective This Past Season, CDC Panel Says
The influenza vaccine was even less effective against A/H1N1pmd09 virus but was better against B/Victoria virus, according to a CDC panel. They also voted on a new meningococcal vaccine.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - June 25, 2020 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news

Model May Help Predict Risk for Testing Positive for COVID - 19
Risk reduced with pneumococcal polysaccharide, flu vaccine; melatonin, paroxetine, or carvedilol use (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - June 25, 2020 Category: Respiratory Medicine Tags: Family Medicine, Infections, Internal Medicine, Critical Care, Emergency Medicine, Pathology, Pharmacy, Pulmonology, Journal, Source Type: news

UNISON demands extra government funding to save universities from crisis
Higher education member Bill Acharjee (above) works at Solent University in Southampton as a research governance officer, with the task of ensuring that students and academics maintain ethical standards while they conduct their research projects. He’s thoughtful, conscientious. And while working from home during the COVID-19 crisis, he has a very sobering thought. “A world without universities would be tragic,” he says. “I just can’t comprehend it.” But there’s a very real danger some may struggle to survive, Mr Acharjee feels, if the government continues to refuse to come to the a...
Source: UNISON Health care news - May 19, 2020 Category: UK Health Authors: Demetrios Matheou Tags: Article News coronavirus higher education Covid-19 Source Type: news

Child vaccinations down in DR Congo, and COVID-19 is not helping: UNICEF
Fewer children are getting vaccinated in the Democratic Republic of the Congo (DRC) and the COVID-19 pandemic is almost certainly going to make matters worse, the United Nations Children’s Fund (UNICEF) says. If the trend continues, it could trigger a resurgence in deadly childhood diseases such as polio, chickenpox, measles, yellow fever, hepatitis B, diphtheria, tetanus, whooping cough and meningitis. (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - May 15, 2020 Category: International Medicine & Public Health Source Type: news

Mandatory BCG vaccination may make COVID-19 less virulent in India, suggests study
The bacille Calmette-Gurin (BCG) vaccine has a documented protective effect against meningitis and disseminated TB in children, according to the World Health Organisation. It is part of the mandatory childhood immunization programme in many countries including India. (Source: The Economic Times)
Source: The Economic Times - May 7, 2020 Category: Consumer Health News Source Type: news

Polio, Measles Outbreaks ‘Inevitable’, Say Vaccine Experts
A young boy in Pakistan receives an oral polio vaccine (OPV). Credit: Ashfaq Yusufzai/IPSBy Laura MackenzieMay 6 2020 (IPS) Interruptions to vaccination programmes caused by the COVID-19 pandemic could result in new waves of measles or polio outbreaks, health experts warn. A growing number of one-off immunisation campaigns and national routine vaccine introductions are being delayed amid social distancing and other measures to curb the spread of SARS-CoV-2, leaving millions unprotected. With both preventive campaigns and routine immunisations impacted, “we’ll have an increasing number of children who will becom...
Source: IPS Inter Press Service - Health - May 6, 2020 Category: International Medicine & Public Health Authors: Laura Mackenzie Tags: Global Headlines Health TerraViva United Nations Source Type: news

MenQuadfi (Meningococcal (Groups A, C, Y, W) Vaccine for Injection) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 6, 2020 Category: Drugs & Pharmacology Source Type: news

FDA Approves MenQuadfi (Meningococcal (Groups A, C, Y, W) Conjugate Vaccine) for Meningococcal (MenACWY) Vaccination
PARIS– April 24, 2020– The U.S. Food and Drug Administration (FDA) has approved a Biologics License Application for MenQuadfi Meningococcal (Groups A, C, Y, W) Conjugate Vaccine for the prevention of invasive meningococcal disease in... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 24, 2020 Category: Drugs & Pharmacology Source Type: news

Vaccine Rates Drop Dangerously as Parents Avoid Doctor ’s Visits
Afraid of Covid-19, parents are postponing well-child checkups, including shots, putting millions of children at risk of exposure to preventable deadly diseases. (Source: NYT Health)
Source: NYT Health - April 23, 2020 Category: Consumer Health News Authors: Jan Hoffman Tags: your-feed-science Vaccination and Immunization Measles Whooping Cough Mumps Diphtheria Coronavirus (2019-nCoV) Babies and Infants Preventive Medicine Epidemics Meningitis your-feed-healthcare Source Type: news

SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia
FOSTER CITY, Calif., March 26, 2020 -- (Healthcare Sales & Marketing Network) -- SutroVax, a biopharmaceutical company dedicated to the delivery of superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious dise... Biopharmaceuticals, Venture Capital SutroVax, conjugate vaccine, vaccine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 26, 2020 Category: Pharmaceuticals Source Type: news

Guidelines for the public health management of clusters of severe pneumococcal disease in closed settings
These Guidelines for managing serious pneumococcal disease in hospitals, care homes, prisons, children's day-care centres and military settings were updated in February 2020, following the introduction of the pneumococcal conjugate vaccine into the national immunisation programme. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - February 26, 2020 Category: Consumer Health News Source Type: news

Dosage Schedule Linked to Rate of PCV Breakthrough Infections Dosage Schedule Linked to Rate of PCV Breakthrough Infections
A dosing schedule that includes three primary doses of pneumococcal conjugate vaccine (PCV) is associated with fewer breakthrough infections in the first year of life than are schedules with two primary doses, according to a new study of surveillance data.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 15, 2020 Category: Allergy & Immunology Tags: Pediatrics News Source Type: news

Cincinnati startup licenses technology invented by renowned children ’s hospital
Blue Water Vaccines Inc., a Norwood startup, has entered into an exclusive worldwide license agreement with St. Jude Children ’s Research Hospital to develop a vaccine for Streptococcus pneumoniae. The bacteria can cause many kinds of diseases, including the lung infection pneumonia. “A major limitation of the currently licensed pneumococcal vaccines is the lack of efficacy against mucosal disease manifestations such as acute otitis media, acute bacterial sinusitis and pneumonia,” Blue Water… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 10, 2020 Category: Pharmaceuticals Authors: Barrett J. Brunsman Source Type: news

Hexavalent Vaccine Included in Vaccines for Children Program
FRIDAY, Feb. 7, 2020 -- The hexavalent combined diphtheria and tetanus toxoids and acellular pertussis (DTaP) adsorbed, inactivated poliovirus (IPV), Haemophilus influenza type b (Hib) conjugate (meningococcal protein conjugate), and hepatitis B... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 7, 2020 Category: Pharmaceuticals Source Type: news

Pneumococcal vaccines are effective -- But new strategies needed to reduce meningitis
(Wolters Kluwer Health) Pneumococcal conjugate vaccines (PCVs) have been highly effective in reducing pneumonia and other invasive infections caused by Streptococcus pneumoniae bacteria. But rates of meningitis have shown little change, as pneumococcal strains not targeted by PCVs emerge as more important causes of meningitis, reports a paper in The Pediatric Infectious Disease Journal, the official journal of The European Society for Paediatric Infectious Diseases. The journal is published in the Lippincott portfolio by Wolters Kluwer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 7, 2020 Category: International Medicine & Public Health Source Type: news

New research into how peace of mind can influence parents' attitude to vaccines
(Meningitis Research Foundation) Research from Bristol University on parents' peace of mind and vaccinations gives us insight that beliefs about vaccines can change, and that peace of mind varies according to different factors. The MenB vaccine, although considered 'new' provided increased reassurance because of the perceived disease severity. Meningitis Research Foundation says parents' peace of mind is currently being ignored when health bodies weigh up vaccine benefits to make decisions whether to introduce vaccines or expand their coverage. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - February 4, 2020 Category: International Medicine & Public Health Source Type: news

Updated Pneumococcal Vaccine Recommendations for Older Adults Updated Pneumococcal Vaccine Recommendations for Older Adults
What do the new PCV13 recommendations mean, and how do you implement them in your practice? Here's what you need to know.CDC Expert Commentary (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - January 31, 2020 Category: Allergy & Immunology Tags: Infectious Diseases Commentary Source Type: news

New study confirms success of MenB vaccine in the UK
MenB vaccination programme has reduced cases of meningitis and septicaemia in young children by almost two-thirds. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 31, 2020 Category: Consumer Health News Source Type: news

MenB vaccination programme evaluation
Public Health England has announced that the MenB vaccination programme has reduced cases of meningitis and septicaemia in young children by almost two-thirds. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 29, 2020 Category: Consumer Health News Source Type: news

PNEUMOSIL ® , the new pneumococcal vaccine, achieves WHO...
Leaders from PNEUMOSIL® collaborators—the Serum Institute of India and the Bill & Melinda Gates Foundation—to speak at the first-ever Global Forum on Childhood Pneumonia on January 29-31,...(PRWeb January 28, 2020)Read the full story at https://www.prweb.com/releases/pneumosil_the_new_pneumococcal_vaccine_achieves_who_prequalification_a_key_step_toward_improving_access_and_affordability/prweb16866771.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 28, 2020 Category: Pharmaceuticals Source Type: news

New study confirms success of MenB vaccine in the UK
MenB vaccination programme has reduced cases of meningitis and septicaemia in young children by almost two-thirds. (Source: NHS Networks)
Source: NHS Networks - January 23, 2020 Category: UK Health Source Type: news

Outbreaks of severe pneumococcal disease in closed settings in the conjugate vaccines era, 20102018: A systematic review to inform national guidance in the UK.
Pneumococcal outbreaks are rare but they still occur, particularly in closed settings usually involving vulnerable groups. The authors undertook a systematic review to identify strategies for controlling pneumococcal outbreaks since the licensure of higher-valent pneumococcal conjugate vaccines (PCVs). (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 16, 2020 Category: Consumer Health News Source Type: news